Abstract — In 2013, U.S. President Barack Obama decreed the creation of the Presidential Commission for the Study of Bioethical Issues, as part of his $100 million Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative. In the wake of the work of this Commission, the purpose, goals, possible shortcomings, and even dangers are discussed, and the possible impact it may have upon neuroscience ethics (Neuroethics) both in clinical practice as well as scientific research.
This interview resulted in the May 14, 2014 article, "U.S. Experts urge focus on ethics in brain research" by Kerry Sheridan, AFP Correspondent. The article was distributed through the NewsCred Smartwire, Agence France Presse.
Kerry Sheridan, Agence France-Presse (AFP): Hi Dr. Faria, I'm working on a story about calls for consideration of ethics in neuroscience research, and I was wondering if I could interview you about your thoughts on the need for ethical oversight in neuroscience?
Since the time of Hippocrates (460-370 B.C.), the Father of Medicine, physicians have traditionally subscribed to doing no harm and prescribed what is in the best interest of their individual patients; in other words, putting their patients first. This concept is known as individual-based ethics.
The new bioethics movement, on the other hand, subscribes to population-based ethics, in which physicians become obligated to make decisions for their patients in concert with what is in the best interest of society or the state.